Cytokines in the Management of High Risk or Advanced Breast Cancer: An Update and Expectation

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|9|8|888-903

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.9, Iss.8, 2009-12, pp. : 888-903

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Docetaxel: An Update of its Use in Advanced Breast Cancer

By Figgitt D.P.   Wiseman L.R.  

Drugs, Vol. 59, Iss. 3, 2000-03 ,pp. : 621-651

Adis International

Access to resources Recommend Favorite

Exemestane and aromatase inhibitors in the management of advanced breast cancer

By Dixon J Michael  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 2, 2004-02 ,pp. : 307-316

Informa Healthcare

Access to resources Recommend Favorite

Anastrozole: A Review of its Use in the Management of Postmenopausal Women with Advanced Breast Cancer

By Wiseman L.R.   Adkins J.C.  

Drugs & Aging, Vol. 13, Iss. 4, 1998-10 ,pp. : 321-332

Adis International

Access to resources Recommend Favorite

Capecitabine: A Review of its Pharmacology and Therapeutic Efficacy in the Management of Advanced Breast Cancer

By Wagstaff A.J.   Ibbotson T.   Goa K.L.  

Drugs, Vol. 63, Iss. 2, 2003-01 ,pp. : 217-236

Adis International

Access to resources Recommend Favorite

ASCO update on breast cancer chemoprevention

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 381, 2002-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite